Treatment With Ledipasvir–Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection-Reference-Cited by-同舟云学术

Treatment With Ledipasvir–Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection

Published:2016-11-15 Issue:2 Volume:166 Page:109
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Colombo Massimo¹,Aghemo Alessio¹,Liu Hong¹,Zhang Jie¹,Dvory-Sobol Hadas¹,Hyland Robert¹,Yun Chohee¹,Massetto Benedetta¹,Brainard Diana M.¹,McHutchison John G.¹,Bourlière Marc¹,Peck-Radosavljevic Markus¹,Manns Michael¹,Pol Stanislas¹

Affiliation:

1. From Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Gilead Sciences, Foster City, California; Hôpital Saint Joseph, Marseilles, and Hôpital Cochin, Paris, France; Medical University of Vienna, Vienna, Austria; and Hannover Medical School, Hannover, Germany.

Funder

Gilead Sciences

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying Gaps in the Treatment Guidelines for Hepatitis C in Peru to Meet International Standards: A Narrative Review;Journal of Clinical Medicine;2024-06-30

2. Hepatitis-C-Therapie vor und nach Nierentransplantation;Die Nephrologie;2024-01-26

3. Cost-effectiveness of Kidney Transplantation From Donors at Increased Risk of Blood-borne Virus Infection Transmission;Transplantation;2023-08-21

4. Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease;Advances in Kidney Disease and Health;2023-07

5. Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection;Clinical Infectious Diseases;2023-05-25